Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06441552
Recruiting Observational

The Natural History of Recovery After Stroke

NCT06441552 · tracked via the Priya Life Science Israel tracker
Phase
Observational
Started
2024-02-01
Last updated
2025-10-03

Condition(s) studied

Cerebral Vascular Accident (CVA)/Stroke

Investigational drug(s) / intervention(s)

non-interventional

non-interventional: non-interventional

Study summary

The goal of this longitudinal observational study is to learn the course of recovery after stroke. Specifically, in this study we will learn and describe the changes in cognitive, motor and sensory function over time in stroke patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * \>18 years of age * Independent in all activities of daily living before the stroke. * In- and out-patients at Adi-Negev Nahalat-Eran rehabilitation center, with first ever stroke, or with a recurrent stroke that did not lead to disability (were independent in ADL before the second stroke). * Medically stable * Able to provide informed consent. Exclusion Criteria: * The presence of any degenerative neurological condition, neuropathy, myopathy or Polio that are not secondary to stroke, excluding diabetic related changes. * Traumatic brain injury and/or extra-cerebral hemorrhage. * Significant psychiatric condition, including alcoholism and drug abuse. * Any severe orthopedic condition (such as amputation or severe pain that limits activity) or chronic pain syndrome. * Participation in another interventional study.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Rambam/Technion Haifa Israel Not Yet Recruiting
Adi-Negev Nahalat Eran Ofakim Israel Recruiting
Al-Ahli hospital Hebron Palestinian Territories Not Yet Recruiting

More Adi Negev-Nahalat Eran trials in Israel

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06441552 on ClinicalTrials.gov ↗ ← All trials in Israel